Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Emcure Pharmaceuticals Ltd

NSE: EMCURE · BSE: 544210 · Pharmaceuticals & Biotechnology · 47 announcements

Emcure Pharmaceuticals Ltd news stories on ALFA NewsRead the news →
Share price
₹1,905.90
Market cap
₹36,157 Cr
Revenue (annual)
₹9,204 Cr
Net profit (annual)
₹924.4 Cr
P/E (TTM)
35.8×Sector 47.4×
Promoter holding
77.83%-0.04% QoQ
FII holding
4.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:08 IST BSE
Management Change

Emcure Pharmaceuticals Management Change

Emcure Pharmaceuticals announced a board reorganization. Mr. Raghu Kumar was appointed as Additional Independent Director, while Mr. Satish Mehta will become Chairman following Mr. Berjis Desai's retirement.

15:49 IST BSE
Management Change

Emcure Pharmaceuticals Management Change

Mr. P.S. Jayakumar has ceased to be an Independent Director of Emcure Pharmaceuticals Limited effective July 21, 2026, following the completion of his second consecutive term.